Silence Therapeutics Ord

(SLNCF)

By |

Profile

Silence Therapeutics PLC is one of the leading companies in the ribonucleic acid (RNA) technology field. The United Kingdom-based firm researches and develops therapeutics to combat highly unmet medical needs. Its patented RNA interference platform, known as AtuRNAi is employed in vaccines to correct genetic deficiencies and infectious diseases by silencing or replacing the expression of virtually any gene in the genome, modulating expression up as well as down in a variety of organs and cell types. Silence's technology is currently in the clinic in a Phase 2a pancreatic cancer trial and its income consists of license fees, milestone and option payments, grant income and fees from research and development collaborations.

Contact Information

Website: www.silence-therapeutics.com
Email: info@silence-therapeutics.com
Main Phone: +44 2034576900
Address: 72 Hammersmith Road
City / Town: London
Country: GBR
Postal Code: W14 8TH

Issuer Information

Exchange: OTO
CEO: David Horn Solomon
Employees: 48


Gathering Data... Please wait

Profile

Silence Therapeutics PLC is one of the leading companies in the ribonucleic acid (RNA) technology field. The United Kingdom-based firm researches and develops therapeutics to combat highly unmet medical needs. Its patented RNA interference platform, known as AtuRNAi is employed in vaccines to correct genetic deficiencies and infectious diseases by silencing or replacing the expression of virtually any gene in the genome, modulating expression up as well as down in a variety of organs and cell types. Silence's technology is currently in the clinic in a Phase 2a pancreatic cancer trial and its income consists of license fees, milestone and option payments, grant income and fees from research and development collaborations.

Contact Information

Website: www.silence-therapeutics.com
Email: info@silence-therapeutics.com
Main Phone: +44 2034576900
Address: 72 Hammersmith Road
City / Town: London
Country: GBR
Postal Code: W14 8TH

Issuer Information

Exchange: OTO
CEO: David Horn Solomon
Employees: 48
$ 0.64 $ 0. (0.00%)
Last Price 0.64 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.64
Last Trade Volume 0 52 Wk Hi 2.85 52 Wk Low 0.62
Market Cap 45.2 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 71,069,933.00 EPS (TTM) -0.09 PE Ratio N/A Exchange OTCPK